Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.99 USD | -1.21% | +7.02% | -10.10% |
2023 | Angion Biomedica Corp. Announces Resignation of Assaf Segal from Its Board of Directors | CI |
2023 | Angion Biomedia to Implement 10-for-1 Reverse Split | MT |
Chart calendar ANGN BIOM
Upcoming events on ANGN BIOM
No events available
Past events on ANGN BIOM
2023-01-18 08:00 am | Elicio Therapeutics and Angion Biomedica Corp. Merger Agreement Call |
2022-08-15 04:05 pm | Interim 2022 Earnings Release |
2022-06-09 11:00 am | Annual General Meeting |
2022-05-24 07:00 am | H.C. Wainwright Global Life Sciences Investment Conference |
2022-05-16 04:05 pm | Q1 2022 Earnings Release |
2022-04-21 11:30 am | Shareholder Equity Conference |
2022-03-30 04:05 pm | FY 2021 Earnings Release |
2022-03-15 03:20 pm | Oppenheimer Healthcare Conference |
2022-03-09 02:10 pm | Cowen & Co. Health Care Conference |
2022-01-10 07:00 am | H.C. Wainwright BioConnect Conference |
2022-01-04 | LifeSci Partners Corporate Access Event |
2021-12-09 04:30 pm | ANG-3777 Phase 2 Trial Results Call |
2021-11-15 03:20 pm | Stifel Healthcare Conference |
2021-11-12 07:00 am | Q3 2021 Earnings Release |
2021-11-03 | American Society of Nephrology Kidney Week Conference |
2021-10-26 04:30 pm | ANG-3777 Phase 3 Trial Results Call |
2021-09-22 10:45 am | Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit |
2021-09-20 10:00 am | Fibrosis R&D Day |
2021-09-13 07:00 am | H.C. Wainwright Global Investment Conference |
2021-08-12 04:05 pm | Interim 2021 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1,49 | 2,88 4,32 -33.27% | 28,3 4,12 587.89% | 2,30 2,30 0% |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | 0,00 | -55,3 -56,0 1.24% | -39,3 -71,1 44.7% | -39,6 -39,0 -1.6% |
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
Net income | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EPS USD | Released Forecast Spread | -43,8 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
Announcement Date | 15/01/21 | 30/03/21 | 30/03/22 | 17/03/23 |
Quarterly results
Fiscal Period | December | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 |
---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,37 1,89 -80.34% | 0,54 0,79 -31.43% | 1,46 1,06 37.41% | 25,9 1,74 1393.01% | 1,65 0,92 79.37% | 0,65 0,78 -15.74% | 0,00 0,63 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -19,9 -14,8 -34.79% | -18,2 -19,3 5.28% | -15,8 -20,1 21.54% | 14,6 -17,1 185.36% | -14,5 -11,9 -21.93% | -9,04 -12,5 27.58% | -6,25 -8,64 27.62% | -7,05 -6,43 -9.73% |
Announcement Date | 17/05/21 | 12/08/21 | 12/11/21 | 30/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 17/03/23 |
Past sector events for ANGN BIOM
- Stock Market
- Equities
- ANGN Stock
- Calendar ANGN BIOM